Research & Development

Hydra Biosciences, Inc., a leader in the field of Transient Receptor Potential (TRP) channel modulation, and Boehringer Ingelheim, one of...

Connexios Life Sciences, a Bangalore based biotechnology company, and Boehringer Ingelheim, one of the world's leading pharmaceutical companies, today announced...

This year's Boehringer Ingelheim FENS Award was granted to Judit Makara from the Institute of Experimental Medicine of the Hungarian...

The European Prevention of Alzheimer’s dementia (EPAD) Initiative is a collaborative research initiative to improve the chance of successfully preventing...

Hydra Biosciences, Inc., a leader in the field of transient receptor potential (TRP) channel modulation, and Boehringer Ingelheim today announced...

Eureka Therapeutics Inc. and Boehringer Ingelheim announced today that they have entered into a research agreement for the discovery of...

Alcon transforms eye care possibilities into therapeutic realities through the discovery and development of innovative eye care products and treatments....

Gencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs...

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development...

U.S. FDA latest regulatory authority to approve SPIRIVA® (tiotropium) Respimat® in asthma1 following authorities in the EU, Japan and other...